Barclays Upgrades Vitamin Shoppe (VSI) to Equalweight

Barclays analyst Karen Short upgraded Vitamin Shoppe (NYSE: VSI) from Underweight to Equalweight with a price target of $6.00 (from $10.00).

The moves back to the sidelines noting the company faces a difficult competitive landscape, eCommerce growth will like pressure GMs and the valuation will remain low dies to headwinds.

For an analyst ratings summary and ratings history on Vitamin Shoppe click here. For more ratings news on Vitamin Shoppe click here.

Shares of Vitamin Shoppe closed at $5.16 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Apollo Hospitals (APLH:IN) PT Raised to INR8,500 at ICICI Securities
• Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins